Benitec Biopharma Inc. is a development-stage biotechnology company focused on the advancement of novel genetic medicines with headquarters in Hayward, California. The proprietary platform, called DNA-directed RNA interference, or ddRNAi, combines RNA interference, or RNAi, with gene therapy to create medicines that facilitate sustained silencing of disease-causing genes following a single administration. The Company is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including Oculopharyngeal Muscular Dystrophy (OPMD), and Chronic Hepatitis B.
Pharmaceutical Preparation Manufacturing (325412)
Pharmaceutical Preparations (2834)
Managing Director, LifeSci Advisors
Benitec Biopharma Inc.
3940 Trust Way
Hayward, CA 94545